1. Bubanovic, I., Najman, S. (2004) Failure of Anti-tumor Immunity in Mammals - Evolution of the Hypothesis. Acta
Biotheoretica. 52:57-64.
2. Rittig, M.G., Kuhn, K.H., Dechant, C.A. et al. (1996) Phagocytes from both vertebrate and invertebrate species use
pooiling-phagocytosis. Dev Comp Immunol. 20:393-306.
3. Ohta, Y., Okamura, K., McKinney, C. et al. (2000) Primitive synteny of vertebrate MHC class I and class II genes. Proc
Natl Acad Sci USA. 97:4712-4717.
4. Lam-Tse, W.K., Lernmark, A., Drexhage, H.A. (2002) Animal models of endocrine/organ-specific auto-immune diseases:
do they really help us to understand human auto-immunity? Springer Semin Immunopathol. 24:297-321.
5. Cua, D.J., Hinton, D.R, Stohlman, S.A. (1995) Self-antigen-induced Th2 responses in experimental allergic
encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of auto-immune disease. J Immunol. 155:4052-4057.
6. Dalal, M., Kim, S., Voskuhl, R.R. (1997) Testosterone therapy ameliorates experimental auto-immune encephalomyelitis
and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol. 159:3-7.
7. Bebo, B.F.Jr., Zelinka-Vincent, E., Adamus, G., et al. (1998) Gonadal hormones influence the immune response to PLP
139±151 and the clinical course of relapsing experimental auto-immune encephalomyelitis. J Neuroimmunol. 84:122-130.
8. Butterworth, M., McClellan, B., Allansmith, M. (1967) Influence of sex in immunoglobulin levels. Nature. 214:1224-1226.
9. London, W.T., Drew, J.S. (1977) Sex differences in response to hepatitis B infection among patients receiving chronic
dialysis treatment. Proc Natl Acad Sci USA. 74:2561-2564.
10. Hilgert, I., Pokorna, Z., Singh, K. et al. (1981) Different efficiency of mercurascan in allograft survival prolongation in
male and female mice. Folia Biol. 27:379-383.
11. Enosawa, S., Hirasawa, K. (1989) Sex-associated differences in the survival of skin grafts in rats: enhancement of
cyclosporine immunosuppression in male compared with female recipients. Transplantation. 47:933-936
12. Fitzpatrick, F., Lepault, F., Homo-Delarche, F. et al. (1991) Influence of castration, alone or combined with thymectomy,
on the development of diabetes in the nonobese diabetic mouse. Endocrinol. 129:1382-1390.
13. Stephanie, M., Liva, R., Rhonda, R.V. (2001) Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10
Production. J Immunol. 167:2060-2067.
14. Rott, O., Fleischer, B., Cash, E. (1994) IL-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol.
24:1434-1438.
15. Cannella, B., Gao, Y.L., Brosnan, C. et al. (1996) IL-10 fails to abrogate experimental auto-immune encephalomyelitis. J
Neurosci Res. 45:735-741.
16. Shaw, M.K., Lorens, J.B., Dhawan, A. et al. (1997) Local delivery of IL-4 by retrovirus-transduced T lymphocytes
ameliorates experimental auto-immune encephalomyelitis. J Exp Med. 185:1711-1718.
17. Bettelli, E., Das, E.P., Howard, E.D, et al. (1998) IL-10 is critical in the regulation of auto-immune encephalomyelitis as
demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 161:3299-330.
18. Houghton, A.N. (1994) Cancer antigens: immune recognition of self and altered self. J Exp Med. 180:1-4.
19. Jager, D., Jager, E., Knuth, A. (2001) Immune responses to tumor antigens: implications for antigen specific
immunotherapy of cancer. J Clin Pathol. 54:669-674.
20. Salih, H.R., Nussler, V. (2001). Immune escape versus tumour tolerance: how do tumours evade immune surveillance? Eur
J Med Res. 27: 323-332.
21. Stavely-2¶&DUURO . 6RWRPD\RU ( 0RQWJRPHU\ - et al. (1998) Induction of antigen-specific T cell anergy: an early
event in the course of tumour progression. Proc Natl Acad Sci USA. 95:1178-1183.
22. Bubanovic, I. (2003) Crossroads of extrathymic lymphocytes maturation pathways. Med Hypotheses. 612:235-239.
23. Palo, J., Duchesne, J., Wikstrom, J. (1977) Malignant diseases among patients with multiple sclerosis. J Neurol. 216: 217-
222.
24. Paul, R., Remes, K., Lakkala, T. et al. (1994) Spontaneous remission in acute myeloid leukaemia. Br J Haematol. 86:210-
212.
25. von Mensdorff-Pouilly, S., Gourevitch, M.M., Kenemans, P., et al. (1996) Humoral immune response to polymorphic
epithelial mucin 1 in patients with benign and malignant breast tumours. Eur J Cancer. 32:1325-1331.
26. Conroy, S.E., Latchman, D.S. (1996) Do heat shock proteins have a role in breast cancer? Br J Cancer. 74:717-721.
27. Bystryn, J.C., Rigel, D., Friedman, R.J. et al. (1987) Prognostic significance of hypopigmentation in malignant melanoma.
Arch Dermatol. 123:1053-1055.
28. Rosenberg, S.A., White, D.E. (1996) Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer
immunotherapy. J Immunother Emphasis Tumor Immunol. 19:81-84.